Member Info for Patagucci

“ While prudently managing costs, we are actively pursuing and refining multiple clinical approaches including company- and investigator-sponsored studies and possibly platform studies (as and when appropriate), to confirm the most expeditious clinical development path for SNG001 in patients hospitalised due to a severe viral lung infection including SARS-CoV-2, influenza, RSV, adenovirus, parainfluenza and rhinoviruses.”

“ Synairgen has adequate cash resources, reaching into Q4 2023, to enable it to determine and pursue its strategic pathway for SNG001, including if necessary the exploration of all options to provide the necessary funds to allow it to continue its clinical development programme”

So we are good for now.

Once the Activ 2 results are in we need trials and a clear road to commercialisation.

So we have something no other drug offers…

The truth is, until this drug is commercialised, we won’t see the returns we are hoping for on our investment. However, this is certainly a very, very, positive step. Looking forward to hearing more about this, and it reminds me why I invested here in the first place.

A broad spectrum antiviral AND the only drug thus far to reduce long covid symptoms.

Those two things are certainly in desperate need.

I was certain of an RNS. Activ 2 data, STRIVE information, sprinter P3 deep dive data, long covid data.

What I didn’t expect was the 2 RNS’s that we got. Mondays was a little more understandable. But data from the COPD trial, did anyone expect that?! I didn’t know that was something we were waiting for…

Seems to have come a bit out of nowhere but fits in nicely with RM’s talk? Is that just coincidence?

When synairgen say positive, you know it’s very very good news. Hopefully this is the tide turning.

I have questions though
1) this new trial, universal, 1000 patients enrolled, are we targeting a certain cohort? It’s for viral respiratory infections, not limited to covid too right.
2) it’s an observational study, what does that mean exactly?
3) what do Janssen get out of this?

Which is owned by J&J…

What would class as a good RNS for you? Evidence that SNG does work in certain cohorts, mainly the elderly? My alarm will most definitely been set, been a while since we’ve had one! Good luck all.

RM tweeting
RNS likely on Monday
Data for P3 released likely too
US trials set to be announced soon
Synairgen on the most commented on section of this forum
The need for the drug as big as ever.

Its good to be back

no I would say its a natural very small correction following what feels like days of red

But looking pretty dark right now, I’m holding tight but can’t help but feeling more impatient by the day. A lot to be announced, I hope I’ll look back in a few months, glad I held.

Money, time, friendships, family, health

If you could pick to loose one it would be money. Big losses are horrible, I’ve been through it. But know that there is so much more to life and you’re worth more than a stupid share price. Hope you’re ok.

Still waiting for
-ACTIV 2 results
-Long Covid data
-Announcements of new trials.

Kurzgesgat is a YouTube channel which explains many scientific problems in great detail, in an easy to understand way. I’ve been watching their videos for years and think they are fantastic.

Their latest video is about the rabies virus, at 2:50, they start to talk about interferon virus. I couldn’t believe it. It seems interferons are becoming increasingly talked about in the scientific world and seeing them discussed on a relatively main stream video like this I think shows the future of interferon medicine is getting closer.

Obviously it’s about the rabies virus and not COVID in this video but still thought it was great to see them mentioned.

https://youtu.be/4u5I8GYB79Y

If the link doesn’t work, just go on to YouTube and search Kurzgesgat rabies.

2.6 million views so far, all publicity is good publicity!

There’s trouble ahead, but hopefully not for us synairgen holders.

Axe, things can be done in haste and still take time. The pyramids, the moon landings, things don't always happen overnight even if we want them to. In fact, most things of importance don't.

I saw Doc’s message on a previous thread with 42 upvotes, good to see there are a fair few of us still around. Sometimes it feels lonely investing in Synairgen, glad to know there are still a few of us out there that see it’s potential.

Really looking forward to seeing updates from the AGM, can’t thank those enough putting in the work behind the scenes!

It’s positive, a decent RNS. Once again EUA promising a bright future but as of now still no sale or anything concrete. I think the BOOOOM is a little premature.

When the SP is back to Ath, rather than multi year lows, then you can say that…

Can I ask guys, don’t want to sound like I’m deramping, but why do people think Synairgen will help with long COVID? Has this ever been suggested in data or by the company?

I can’t agree more, I spent the last 3 years researching companies to invest in. I have most my money in boring index funds, but of my fun money, I put the majority in Synairgen, and some in 4D… well, even when you think all the stars are aligned, you never know what will happen.

What I learnt from Synairgen, don’t invest in a company with only one product
What I learnt from 4D, avoid companies with debt? I don’t know, still working this one out.

Partnered with a major pharma, drugs which I believed were the future, good trial results… shocking really.

What would you be happy with? Anything less than £1 is a disaster imo